-
UPDATE: Morgan Stanley Reiterates On Telefonica Brasil SA Despite Trimmed Estimates
Friday, May 9, 2014 - 9:31am | 101In a report published Friday, Morgan Stanley analyst Michel Morin reiterated an Overweight rating on Telefonica Brasil SA (NYSE: VIV), and raised the price target from $22.00 to $23.00. In the report, Morgan Stanley noted, “We are raising our DCF-based target to $23/ADR from $22 due to FX, as we...
-
UPDATE: Morgan Stanley Reiterates On Mercadolibre On Heightened Macro Risks
Friday, May 9, 2014 - 8:52am | 92In a report published Friday, Morgan Stanley analyst Michel Morin reiterated an Underweight rating on Mercadolibre (NASDAQ: MELI), but lowered the price target from $70.00 to $64.00. In the report, Morgan Stanley noted, “MELI is an ecommerce leader in Latam with solid long-term growth potential,...
-
UPDATE: Morgan Stanley Reiterates on America Movil SAB de CV on Doubling Down in Austria
Thursday, April 24, 2014 - 10:29am | 159In a report published Thursday, Morgan Stanley analyst Michel Morin reiterated an Equal-Weight rating on America Movil SAB de CV (NYSE: AMX), but removed the $20.00 price target. In the report, Morgan Stanley noted, “Our preliminary estimate is that the increased investment in Telekom Austria...
-
Morgan Stanley Remains Muted on Mercadolibre Following 4Q13 EPS
Friday, February 28, 2014 - 9:55am | 83In a report published Friday, Morgan Stanley analyst Michel Morin reiterated an Underweight rating and $75.00 price target on Mercadolibre (NASDAQ: MELI). In the report, Morgan Stanley noted, “Results beat consensus and MSe, but KPIs were mixed. MELI is an ecommerce leader in Latam with solid long...
-
UPDATE: Morgan Stanley Reiterates on Grupo Televisa SAB with Regulatory Change on the Horizon
Tuesday, February 25, 2014 - 9:18am | 132In a report published Tuesday, Morgan Stanley analyst Michel Morin reiterated an Overweight rating on Grupo Televisa SAB (NYSE: TV), but lowered the price target from $38.00 to $37.00. In the report, Morgan Stanley noted, “We expect Mexico's new regulator to declare by March 9 whether Televisa and...
-
UPDATE: Morgan Stanley Reiterates On America Movil On Trimmed EBITDA Estimates
Friday, February 14, 2014 - 10:26am | 92In a report published Friday, Morgan Stanley analyst Michel Morin reiterated an Equal-Weight rating on America Movil (NYSE: AMX), but lowered the price target from $21.00 to $20.00. In the report, Morgan Stanley noted, “Trimming EBITDA estimates by 1-2% following 4Q results. The larger cut to...
-
UPDATE: Morgan Stanley Reiterates On TIM Participacoes Following Strong EBITDA, Weak Revenue
Friday, February 14, 2014 - 10:12am | 106In a report published Friday, Morgan Stanley analyst Michel Morin reiterated an Equal-Weight rating on TIM Participacoes (NYSE: TSU), but removed the $26.00 price target. In the report, Morgan Stanley noted, “EBITDA of R$1.50bn (+5% y/y) beat our estimate of R$1.36bn by 11% and consensus by 7%....
-
UPDATE: Morgan Stanley Reiterates on America Movil Following In-Line 4Q
Wednesday, February 12, 2014 - 9:49am | 144In a report published Wednesday, Morgan Stanley analyst Michel Morin reiterated an Equal-Weight rating on America Movil (NYSE: AMX), but removed the $21.00 price target. In the report, Morgan Stanley noted, “EPADR of US$0.37 missed our US$0.49 and consensus of US$0.44 on higher than expected FX...
-
UPDATE: Morgan Stanley Downgrades Mercadolibre on Poor Risk-Reward
Monday, November 18, 2013 - 12:24pm | 93In a report published Monday, Morgan Stanley analyst Michel Morin downgraded the rating on Mercadolibre (NASDAQ: MELI) from Equal-Weight to Underweight, but named a $75.00 price target. In the report, Morgan Stanley noted, “Valuation does not adequately reflect growing macro risks in our view....
-
UPDATE: Morgan Stanley Downgrades NII Holdings on Significant Operating Challenges, Growing Debt Burden
Thursday, August 22, 2013 - 10:58am | 90In a report published Thursday, Morgan Stanley analyst Michel Morin downgraded the rating on NII Holdings (NASDAQ: NIHD) from Equal-Weight to Underweight, but named a $4.00 price target. In the report, Morgan Stanley noted, “NIHD faces significant operating challenges and a growing debt burden....